These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20835636)

  • 1. The SF-6D Brazil questionnaire: generation models and applications in health economics.
    Campolina AG; Bortoluzzo AB; Ferraz MB; Ciconelli RM
    Rev Assoc Med Bras (1992); 2010; 56(4):409-14. PubMed ID: 20835636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Brazilian version of the generic six-dimensional short form quality of life questionnaire (SF-6D Brazil)].
    Campolina AG; Bortoluzzo AB; Ferraz MB; Ciconelli RM
    Cien Saude Colet; 2011 Jul; 16(7):3103-10. PubMed ID: 21808898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the SF-6D index in Brazilian patients with rheumatoid arthritis.
    Gonçalves Campolina A; Bruscato Bortoluzzo A; Bosi Ferraz M; Mesquita Ciconelli R
    Clin Exp Rheumatol; 2009; 27(2):237-45. PubMed ID: 19473563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.
    Bansback N; Marra C; Tsuchiya A; Anis A; Guh D; Hammond T; Brazier J
    Arthritis Rheum; 2007 Aug; 57(6):963-71. PubMed ID: 17665482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of health-related quality-of-life measurement instruments in diabetic patients.
    Yordanova S; Petkova V; Petrova G; Dimitrov M; Naseva E; Dimitrova M; Petkova E
    Biotechnol Biotechnol Equip; 2014 Jul; 28(4):769-774. PubMed ID: 26019561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
    Sørensen J; Linde L; Ostergaard M; Hetland ML
    Value Health; 2012; 15(2):334-9. PubMed ID: 22433765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Wallenstein G
    J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
    Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population.
    Ferraz MB; Nardi EP; Campolina AG
    Value Health Reg Issues; 2019 Dec; 20():21-27. PubMed ID: 30634088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.
    Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Verstappen SM; Watson K; Symmons DP;
    Qual Life Res; 2009 Nov; 18(9):1195-205. PubMed ID: 19777373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.
    Amjadi SS; Maranian PM; Paulus HE; Kaplan RM; Ranganath VK; Furst DE; Khanna PP; Khanna D;
    J Rheumatol; 2009 Jun; 36(6):1150-7. PubMed ID: 19369459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.